Wegovy Reduces BMI in Kids With Obesity as Young as 6

Summary
(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...
Description from Medpagetoday.
Who is covering this
-
Wegovy Reduces BMI in Kids With Obesity as Young as 6
(MedPage Today) -- NATIONAL HARBOR, Md. -- Young children ages 6 to 11 years with obesity lost significant weight with the GLP-1 medication semaglutide (Wegovy), according to results from the phase III STEP Young trial. At week 68, mean body...
Comments
Comments need JavaScript.